FDA
-
-
-
-
-
-
-
Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS
-
-
-
-
-
-
-
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN
-
-
-
-
-
-
-
Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
-
-
-
-
-
-
-
H.C. Wainwright Starts Geron Corporation (GERN) at Buy
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

